ESSA Pharma (EPIX) Stock Forecast, Price Target & Predictions
EPIX Stock Forecast
ESSA Pharma stock forecast is as follows: an average price target of $9.50 (represents a 493.75% upside from EPIX’s last price of $1.60) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
EPIX Price Target
The average price target for ESSA Pharma (EPIX) is $9.50 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $17.00 to $2.00. This represents a potential 493.75% upside from EPIX's last price of $1.60.
EPIX Analyst Ratings
According to 1 Wall Street analysts, ESSA Pharma's rating consensus is 'Hold'. The analyst rating breakdown for EPIX stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
ESSA Pharma Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 04, 2024 | Joseph Catanzaro | Piper Sandler | $2.00 | $1.63 | 22.70% | 25.00% |
| Sep 16, 2024 | Leland Gershell | Oppenheimer | $17.00 | $6.85 | 148.18% | 962.50% |
| Sep 16, 2024 | Tyler Van Buren | Piper Sandler | $15.00 | $6.85 | 118.98% | 837.50% |
The latest ESSA Pharma stock forecast, released on Nov 04, 2024 by Joseph Catanzaro from Piper Sandler, set a price target of $2.00, which represents a 22.70% increase from the stock price at the time of the forecast ($1.63), and a 25.00% increase from EPIX last price ($1.60).
ESSA Pharma Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $2.00 | $11.33 |
| Last Closing Price | $1.60 | $1.60 | $1.60 |
| Upside/Downside | -100.00% | 25.00% | 608.13% |
In the current month, the average price target of ESSA Pharma stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ESSA Pharma's last price of $1.60. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 04, 2024 | Piper Sandler | Overweight | Neutral | Downgrade |
| Nov 04, 2024 | Oppenheimer | Outperform | Perform | Downgrade |
| Sep 16, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Sep 16, 2024 | Piper Sandler | Overweight | Overweight | Hold |
ESSA Pharma's last stock rating was published by Piper Sandler on Nov 04, 2024. The company Downgrade its EPIX rating from "Overweight" to "Neutral".
ESSA Pharma Financial Forecast
ESSA Pharma Revenue Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - |
| # Analysts | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - |
ESSA Pharma's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. EPIX's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
ESSA Pharma EBITDA Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - |
undefined analysts predict EPIX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than ESSA Pharma's previous annual EBITDA (undefined) of $NaN.
ESSA Pharma Net Income Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - |
| Avg Forecast | $-3.77M | $-3.77M | $-5.10M | $-7.99M | $-8.34M | $-10.91M |
| High Forecast | $-3.77M | $-3.77M | $-5.10M | $-7.99M | $-6.58M | $-10.91M |
| Low Forecast | $-3.77M | $-3.77M | $-5.10M | $-7.99M | $-10.97M | $-10.91M |
| Surprise % | - | - | - | - | - | - |
ESSA Pharma's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. EPIX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
ESSA Pharma SG&A Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - |
ESSA Pharma's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to EPIX last annual SG&A of $NaN (undefined).
ESSA Pharma EPS Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - |
| Avg Forecast | $-0.09 | $-0.09 | $-0.12 | $-0.18 | $-0.19 | $-0.25 |
| High Forecast | $-0.09 | $-0.09 | $-0.12 | $-0.18 | $-0.15 | $-0.25 |
| Low Forecast | $-0.09 | $-0.09 | $-0.12 | $-0.18 | $-0.25 | $-0.25 |
| Surprise % | - | - | - | - | - | - |
According to undefined Wall Street analysts, ESSA Pharma's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to EPIX previous annual EPS of $NaN (undefined).